Patient Leaflet Updated 22-Dec-2023 | ADVANZ Pharma
Thiopental powder for solution for injection
Thiopental 0.5 g powder for solution for injection
Thiopental 1 g powder for solution for injection
thiopental sodium
The name of your medicine is Thiopental 0.5/1 g powder for solution for injection (called Thiopental Injection in this leaflet).
1. What Thiopental Injection is and what it is used for
2. What you need to know before you are given Thiopental Injection
3. How Thiopental Injection is given
4. Possible side effects
5. How to store Thiopental Injection
6. Contents of the pack and other information
Thiopental Injection contains the active substance “thiopental sodium”. It is a thiobarbiturate with rapid onset for intravenous administration.
Thiopental Injection is used:
Talk to your doctor or nurse before you are given Thiopental Injection. The health care professionals should be extra careful and may have to adjust your dose, if you have/are:
Tell your doctor or nurse if you are using, have recently used or might use any other medicines.
The following medicines can affect or can be affected by this injection and may need to be adjusted before or after receiving this injection:
The dose of Thiopental Injection may need to be increased if you are addicted to or regularly consume large amounts of alcohol.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Thiopental Injection should be given to a pregnant woman only if the doctor considers it to be clearly necessary.
Thiopental is excreted in breast milk; breastfeeding should be temporarily suspended (for at least 12 hours after the use of thiopental) or breast milk expressed before the use of Thiopental Injection.
Thiopental Injection has major influence on the ability to drive and use machines. Although recovery is relatively quick, you may experience periods of vertigo, disorientation and sedation. Patients therefore must not drive and use machines within 24 to 36 hours after the use of Thiopental Injection.
One vial of Thiopental Injection 0.5 g contains 51-56 mg (or 2.2-2.4 mmol) sodium (main component of cooking/table salt) and one vial of Thiopental Injection 1 g contains 102-112 mg (or 4.4-4.9 mmol) sodium. This is equivalent to 2.8% (0.5 g vial) and 5.6% (1 g vial) of the recommended maximum daily dietary intake of sodium for an adult.
Thiopental Injection will be given to you by a healthcare professional trained in anaesthesiology, who will be constantly available during the administration of Thiopental Injection as will emergency resuscutative equipment.
Thiopental Injection will be given directly into one of your blood vessels, a vein (intravenously).
A test dose will be given in order to adjust the dose according to your needs.
Anaesthesia
Your individual dose will be determined by the doctor and it will be based on your age, sex, body weight and general condition. You will receive a dose to start the anaesthesia and additional injections to maintain the anaesthesia.
Seizures/convulsions
The injection of Thiopental Injection should be given as soon as possible after the convulsion begins. Further doses may also be required to control convulsions.
Intracranial pressure
You will receive a dose based on your body weight in order to reduce elevations of pressure in the skull (respiratory assistance is provided).
Impaired liver or kidney function
Your doctor will reduce the dose of Thiopental Injection if you have impared liver or kidney fuction.
It is unlikely that you receive an excessive dose, since healthcare personnel takes care of the administration of Thiopental Injection.
Overdose may occur from too many injections or if Thiopental Injection is administered too quickly. In the event of suspected or apparent overdose, the drug should be discontinued. Symptoms of overdose include: alarming fall in blood pressure, shock. In addition apnea, coughing and other breathing difficulties may occur (this however, can also be a sign of underdosing).
If you have any further questions on the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately if you notice any of the following symptoms - you may need urgent medical treatment:
Other side effects that may occur:
Common: may affect up to 1 in 10 people
Not known: frequency cannot be estimated from the available data
At the beginning when given Thiopental Injection, laryngeal spasm, coughing and sneezing may occur. After the operation and use of Thiopental Injection, vomiting is uncommon but persistent drowsiness, confusion, amnesia and shivering may occur.
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Before the first opening: The medicinal product does not require any special storage conditions.
After reconstitution: Store in a refrigerator (2°C–8°C) for a maximum of 24 hours.
Store in room temperature for a maximum of 6 hours.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Glass vial with bromobutyl rubber stopper and aluminium seal, in a carton box.
Content of the pack:
Thiopental Injection powder for solution for injection 0.5 g: 1 x 1 vial, 10 x 1 vial, 20 x 1 vial or 50 x 1 vial
Thiopental Injection powder for solution for injection 1 g: 1 x 1 vial, 10 x 1 vial, 20 x 1 vial or 50 x 1 vial
Not all pack sizes may be marketed.
This leaflet was last revised in December 2023.
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK
+44 (0)208 588 9131
www.advanzpharma.com
+44 (0)208 588 9131
+44 (0)208 588 9273